Inside Stanford's virtual biotech: 37,000 AI agents, no humans, full drug pipeline
Dr_Singularity · x · 2026-09-20
Stanford Medicine details how James Zou's lab, with graduate student Harrison Zhang, spun out a virtual biotech company from its 2025 virtual lab: 37,000 employees, all AI agents covering the full pipeline from target discovery to clinical trial design, with no lab space or payroll. The AI company predicted drug trial success and independently designed a lung cancer therapy later validated in trials.
Related event: Stanford Builds Virtual Pharma Company Run by 37,000 AI Agents(2 posts)→
More from AGI Musings
- When 25 Fields Medalists Weigh In on AI, I Trust No One More, Says AI Researcher — wordgrammer · 2026-09-20
- Same ChatGPT, Same $20: Why One Consultant Saves 20 Hours a Week and His Coworker Saves 30 Minutes — Aiden_Tech_Ai · 2026-09-20
- Ethics 101 gloss misleads: all three theories value consequences, rules, and virtues — gleech · 2026-09-20
- Bostrom in 2023 warned AI panic could trigger a 2026 total ban on superintelligence — Dan_Jeffries1 · 2026-09-20
- Agents are silently doing product workarounds users were stuck with — invisibly shaping roadmaps — jacalulu · 2026-09-20
- 362 tracked LLM incidents among 1.2B users: a 0.00003% harm rate? — Dan_Jeffries1 · 2026-09-20